We investigated whether the 20 prognostic proteins offered an improvement in risk estimation in addition to the only prognostic protein biomarker currently in use in pulmonary arterial hypertension, namely NT-proBNP. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.